Biogen continues to sink
World of DTC Marketing
FEBRUARY 7, 2022
According to Endpoint News” We’ve seen Biogen’s CSO exit under pressure in recent weeks, and senior marketing execs leave in an exodus as the company recoiled from a fierce backlash against the FDA’s ultra controversial approval of Aduhelm for Alzheimer’s. Click to Tweet.
Let's personalize your content